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ABSTRACT 
Ground-based analogs of spaceflight are an important means of studying physiological and 
nutritional changes associated with space travel, particularly since exploration missions are 
anticipated, and flight research opportunities are limited. A clinical nutritional assessment of the 
NASA Extreme Environment Mission Operation V (NEEMO) crew (4 M, 2 F) was conducted 
before, during, and after the 14-d saturation dive. Blood and urine samples were collected before 
(D-12 and D-1), during (MD 7 and MD 12), and after (R + 0 and R + 7) the dive. The foods 
were typical of the spaceflight food system. A number of physiological changes were reported 
both during the dive and post dive that are also commonly observed during spaceflight. Serum 
hemoglobin and hematocrit were decreased (P < 0.05) post dive. Serum ferritin and 
ceruloplasmin significantly increased during the dive, while transferrin receptors tended to go 
down during the dive and were significantly decreased by the last day (R + 0). Along with 
significant hematological changes, there was also evidence for increased oxidative damage and 
stress during the dive. 8-hydroxydeoxyguanosine was elevated (P < 0.05) during the dive, while 
glutathione peroxidase and superoxide disrnutase activities were decreased (P < 0.05) during the 
dive. Serum C-reactive protein (CRP) concentration also tended to increase during the dive, 
suggesting the presence of a stress-induced inflammatory response, Decreased leptin during the 
dive (P < 0.05) may also be related to the increased stress. Similar to what is observed during 
spaceflight, subjects had decreased energy intake and weight loss during the dive. Together, 
these similarities to spaceflight provide a model to fiu-ther define the physiological effects of 
spaceflight and investigate potential countermeasures. 
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INTRODUCTION 
Nutrition is essential for the maintenance of crew health before, during, and after spaceflight. 
Several physiological changes occur during spaceflight, including bone and muscle loss (l), 
oxidative damage (2), cardiovascular, and hematologic alterations (3). These may involve 
altered nutritional status to one degree or other. Ground-based models have been used 
extensively to study human adaptation to spaceflight (4), including disuse (e.g., bed rest) and 
isolation (e.g., Antarctic, closed chamber studies). Underwater analogs have also been used to 
simulate the isolation, stress, and constraints of spaceflight. They are used to better understand 
physiological and psychological effects on humans, to assess training and operational issues, to 
evaluate hardware and procedures, and to test the effectiveness of potential countermeasures. 
One underwater-based analog was named the NASA Extreme Environment Mission Operation 
(MEMO) project, where subjects live in an underwater habitat for extended periods of time. 
The unique underwater laboratory provides an environment similar to that aboard the 
International Space Station (ISS). Not only is the habitat similar in size to modules of the ISS, 
but the “aquanauts” coordinate operations remotely via a mission control center located onshore 
(4.5 km away), and also perform extensive science and extravehicular activities during the 
mission. In some cases, as in the study reported here, the foods provided to the crew are the 
same as those provided to astronauts on the ISS. 
The environment in the habitat emulated stress-induced physiological changes commonly 
observed during spaceflight (5 )  and in other ground-based analogs (6). One mechanism by 
which physiological changes occur during spaceflight is the increased stress due to 
environmental changes such as acceleration during lift-off, weightlessness, confinement, and 
long-term maintenance of high levels of performance. These types of stress induce hormonal 
56 changes and altered immune function (7-9). Furthermore, while these stress-induced changes are 
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known to occur during spaceflight, the confounding effects of altered nutritional status (and the 
effects on nutritional status) are not well understood and need to be clarified in order to define 
nutritional requirements for long-term spaceflight. 
The aim of this study was to evaluate the nutritional status of subjects in a ground-based 
analog of spaceflight, the fifth NEEMO mission (NEEMO V). A comprehensive nutritional 
assessment was conducted before, during, and after the mission. We hypothesized that in 
addition to the effects of stress and confinement, that unique characteristics of the mission and 
habitat (e.g., increased atmospheric pressure) would also impact nutrition and health. 
METHODS 
Environment 
NEEMO V was a 14-d saturation dive, with the crew (n = 6) living in an underwater habitat. 
The habitat is 14 m long and 4 m in diameter (Figure 1). It is located 20 m (47 ft) below the 
ocean surface, with an atmospheric pressure inside the habitat of 2.5 atm. The NEEMO V 
mission was completed in June - July of 2003. Supplies were transferred down to the habitat via 
sealed container, and samples were returned to the surface via the same container. All tubes and 
hardware were pre-tested to ensure that the pressure change would not alter function. Because of 
the nature of the dive (i.e., extended-duration saturation dive), a 17-h decompression was 
required prior to resurfacing. 
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Subjects 
The crew for NEEM0 V consisted of 2 females and 4 males. Three of the six were astronauts 
(one with previous flight experience), one was a scientist fkom the Johnson Space Center, and the 
remaining two were technicians responsible for the maintenance of the habitat. The average age 
was 35.7 k 6.6 y (mean *SD). All subjects were required to pass an Air Force Class 111 physical 
and were required to have logged a minimum of 25 dives prior to participation in the study. 
Before the dive, the average body weight was 69.9 k 17.3 kg. Body fat mass, bone mineral 
content, and lean body mass were also recorded for 4 of the crewmembers (15.3 k 2.25,2.5 1 k 
0.69, and 52.1 k 14.5 kg, respectively). 
Subjects were trained on all procedures required for the successful completion of the in dive 
sample and data collections. Pre-dive dietary data was collected fkom a standard food frequency 
questionnaire (REF), while in-dive food intakes were recorded for each meal using a bar code 
reader. Dietary training was provided by the research dietitian (BLR). Two of the crewmembers 
were trained in phlebotomy techniques, and they subsequently collected all pre- and in-dive 
blood samples. 
Body mass and body composition determinations 
Body mass was determined using a calibrated scale on the days when body composition was 
determined, and using a standard scale on all other days. For the in-dive determinations, a 
standard scale was tested in the habitat and was found to function reliably in the high pressure 
atmosphere. This scale was subsequently used for the remainder of the study. 
Body composition was determined (4 subjects only) before and after the dive using dual 
energy x-ray absorptiometry (DEXA). Dual-energy x-ray absorptiometry @ E m )  scans were 
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performed using a Hologic QDR 4500W (Hologic, Inc., Waltham, MA) fan beam densitometer. 
Whole body scans were performed before and after the mission for body composition 
assessment. 
Sample Collection and Processing 
Blood (25.7 mL) was collected before (dive minus twelve days, D-12 and D-l), during the 
dive [mission day 7 (MD 7) and MD 121, and post-dive (return plus zero days, designated R + 0, 
and R + 7). For two of the subjects, the first pre-dive collection was completed at D-5/-4. Blood 
collections were performed at the same time each day following an 8-h fast. 
Urine was collected before (D-12, D-1 1, D-1; except for two subjects where samples were 
collected on D-5, D-4, and D-1), during (MD 7, MD 12), and after the dive (R + 0, R + 1, R + 7, 
and R + 8). Pre- and post-dive samples were collected in individual bottles and stored cool until 
processing (<24 hours). During the dive, the crew collected voids either into a beaker or a 
graduated cylinder. Volumes were recorded, and a 50 mL aliquot from each void was sent to the 
surface. All urine and blood samples were kept in a cooler on ice in the habitat before (and 
during) ascent to the surface. The samples were also kept on ice aboard the boat when returning 
to shore. 24-h pools were created based on void volumes, and aliquots were prepared and frozen 
for analysis as soon as possible on shore. 
For tests where storage would alter the results (e.g., malondialdehyde, hematocrit, and 
hemoglobin), these were run in the laboratory facilities on shore. Others remained frozen on dry 
ice until return to the Johnson Space Center in Houston. 
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Biochemical Analyses 
Most analytical determinations were completed using standard, commercial techniques as 
described previously (6). Hemoglobin, hematocrit (calculated), and mean corpuscular volume 
were determined using a Coulter T890 instrument (Beckman Coulter, Brea, CA). Serum ferritin 
and transferrin were analyzed using the Imrnulite (Diagnostics Products, Los Angeles, CA) and 
Array 360 instruments, respectively (Beckman Coulter). Transferrin receptors were measured 
using a commercially available ELISA (Ramco Laboratories, Houston, TX). RBC folate was 
measured using a commercially available radioreceptor assay (Diagnostic Products, Los Angeles, 
CA). Ferritin iron content was determined by ICP-MS using a method previously described (6). 
Whole blood ionized calcium and electrolytes were determined using ion-sensitive electrode 
techniques with aportable analyzer (i-STAT, Princeton, NJ) (6,lO) . Despite attempts to use the 
portable device in situ during the mission, the pressure differential did not allow for proper 
hctioning of the device. These tests were subsequently performed on samples once they were 
returned to the surface. 
Urine and serum total calcium was measured by inductively coupled plasma emission mass 
spectrophotometry techniques (1 1). Serum intact parathyroid hormone was measured by RIA 
(Nichols Institute Diagnostics, San Juan Capistrano, CA). Vitamin D metabolites 25- 
hydroxyvitamin D and 1,25-dihydroxyvitmin D were also determined using commercially 
available kits (DiaSorin, Stillwater, MN). Bone-specific alkaline phosphatase was measured by 
ELISA (Quidel Corp, Santa Clara, CA, USA). Serum osteocalcin was measured by commercial 
radioimmunoassay (Biomedical Technologies). 
Urine samples were analyzed for collagen cross-links using commercially available kits 
(METRA PYD and DPD EL4 kits, Quidel Corp.; and Osteomark ELISA kit; Ostex International, 
145 Inc., Seattle, WA, USA) as previously described (12). Crosslink data were expressed as m o l  
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excretion per day, as we have demonstrated that this reduces within-subject variability (13). 
RBC superoxide dismutase, glutathione peroxidase, and serum oxygen-radical absorbance 
capacity were measured spectrophotmetricall y using commercially available kits (Randox 
Laboratories, Crumlin, UK). HPLC techniques (14) were used to determine 8-hydroxy-2’- 
deoxyguanosine in urine. Plasma MDA was measured using a commercially available kit 
(Calbiochem Lipid Peroxidation Assay kit, EMD Biosciences, Inc., San Diego, CA). 
Serum total protein, cholesterol, triglycerides, sodium, potassium, chloride, aspartate 
aminotransferase, alanine aminotransferase, RBC transaminase, and total alkaline phosphatase 
were analyzed using a Beckman CX7 automated clinical chemistry system (Beckman Coulter, 
Brea, CA). Serum albumin and transthyretin were analyzed using the Beckman Appraise and 
Array 360 instruments, respectively (Beckman Coulter). Urine creatinine was analyzed on the 
NexCT (Alfa Wassermann, West Caldwell, NJ). 
Statistical Analysis 
Data are reported as means rt SD. Dietary data and biochemical data were analyzed using 
repeated-measures analysis of variance (ANOVA) with a post-hoc Bonferroni test to determine 
differences among groups. Statistical analyses were performed using Sigmastat (SPSS, Chicago, 
IL). 
RESULTS 
167 Dietary Intake 
168 Pre-dive dietary intakes were determined (mean f SD) for energy, fat, protein, calcium, and 
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iron (2100 f 613 kcal, 84.7 1- 24.2 g, 83.1 f 33.0 g, 774 f 327 mg, and 19.7 f 14.4 mg, 
respectively) using a food frequency questionnaire. Energy intake was significantly lower than 
the World Health Organization recommendations during the dive on MD 5, MD 6, and MD 1 1 
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(Table 1). Mid-dive means (Ir SD) were also determined for vitamin D, fat, protein, calcium, 
and iron (5.46 f 5.28 pg, 63.3 k 20 g, 77.5 k 28 g, 1002 f 387 mg, and 22.3 k 9.56 mg, 
respectively). 
Body Weights and Composition 
Body weights were significantly lower from pre dive weights on MD 7-14 (P < 0.05), and 
higher than pre dive weights on R + 7 (Table 1). Body fat, bone mineral content, and lean body 
mass were not different (n=4) when these measurements from R + 7 were compared with pre 
dive measurements (Table 1). 
Hematology and general chemistry 
Hemoglobin and hematocrit were both decreased (P < 0.05) at R + 0 compared to pre dive 
and MD7 (Table 2). Serum mean corpuscular volume (MCV) was significantly decreased (P < 
0.05) on the last collection day post flight (R + 7) compared to in-dive (MD 7 and MD 12) and R 
+ 0 (Table 2). There was a significant decrease in serum iron post dive (R + 7) compared to in- 
dive (MD 7 and MD 12). 
Serum ferritin was significantly elevated both days in-id dive and R + 0 compared to pre and 
post (R + 7) dive (Table 2). Similarly, serum ceruloplasmin tended to increase during the dive 
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and was significantly elevated R + 0 (Table 3). Transferrin receptors in serum tended to 
decrease in-dive but the decrease compared to pre dive was only significant on R + 0 (Table 2). 
Ferritin iron, transferrin, and ferritin saturation were unchanged throughout the study. 
Triglycerides were elevated post dive (R + 7) compared to pre dive. Serum leptin tended to 
decrease during the dive and was significantly different from pre dive on R + 0 (Table 3). 
Electrolyte pools were also altered in response to conditions during NEEM0 V. Sodium and 
chloride excretion were decreased (P < 0.05) during the dive (MD 7 and MD 12) compared to 
pre dive (Table 4), while urine excretion volume remained constant during the study. Serum 
sodium concentration was significantly higher during the dive (MD 7 and MD 12) and after the 
dive (R + 7) compared to pre dive (P < 0.05, Table 3). Whole blood sodium and 
potassium., ... showed the same changes? (data in table, or data not shown.. .) 
Calcium and bone metabolism 
Urinary calcium was significantly elevated post-dive (R + 8) compared to mid-dive (MD 12) 
(Table 5). Serum total calcium was unaltered during the study; however, serum ionized calcium 
was increased (P < 0.05) on MD 12 and post dive (R + 7) compared to pre dive (Table 5). 
Urinary collagen crosslinks (NTX, PYD, and DPD) were unaffected during or after the dive. 
Serum osteocalcin was significantly elevated post dive (R + 7) compared to in-dive (MD 7 
and MD12), but other markers of bone formation including serum total alkaline phosphatase and 
bone-specific alkaline phosphatase were unchanged during the study (Table 5). Similarly, there 
was no effect on serum vitamin D metabolites, 25-hydroxy vitamin D or 1,25-dihydroxy vitamin 
D (Table 5). 
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Urinary 8-hydroxy 2’-deoxyguanosine (80HdG) excretion was significantly elevated during 
the dive (MD 7 and MD12) compared to pre dive (P 0.05) (Table 6). Other markers of 
antioxidant status and h c t i o n  were also altered during and post dive, including whole blood 
glutathione peroxidase (GPX) activity, superoxide dismutase (SOD) activity, and plasma 
malondialdehyde (MDA). Whole blood GPX tended to decrease during the dive and R + 0 but it 
was not significantly decreased until R + 7 (Table 6). Whole blood SOD was decreased MD 7, 
and this significant decrease (P < 0.05) compared to the pre dive continued throughout the 
remainder of the study (MD 12, R + 0, and R + 7). Plasma MDA was significantly decreased 
post dive (R + 0 and R + 7) compared to pre dive. Red blood cell glutathione reductase activity 
was decreased (P < 0.05) at the latter part of the dive (MD 12 and R + 0), but was returned to pre 
dive concentrations 7 d after the dive (Table 3). 
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Limitations on resources ( e g ,  time, power, volume, up/down mass) for spaceflight research 
necessitate the development of Earth-based analogs. The underwater isolation of the NEEM0 
missions provides one such analog of spaceflight, with obvious similarities, along with obvious 
limitations. The study we report here clearly identifies this as a valuable analog environment, 
with results that resemble many aspects of spaceflight beyond the direct nutritional implications 
(e.g., dietary intake). In further defining the changes that occurred in crew members, we will be 
better able to propose, design, and test countermeasures for future missions. 
The hematological findings are striking, and extend those from earlier dive studies, as well as 
apply to hematological changes seen during spaceflight. Reductions in hemoglobin 
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concentration and increases in serum ferritin concentration are well established in deep saturation 
dives (depths up to 660 m, 31 - 67 atm) (15-17). These same effects were observed after the 14- 
d shallow saturation dive described here (14.3 m, 2.5 atm). Reduced hemoglobin concentrations 
suggest a reduction in red blood cell mass, which could be due to decreased production of new 
red blood cells, as seen in spaceflight (1 8), or destruction of existing red blood cells by oxidative 
damage (15,19). 
Increased serum ferritin in-dive and decreased transferrin receptors R + 0 were also observed 
and would be expected when iron stores and intracellular iron availability are high. It is likely 
that the increased oxygen availability, induced by the increased atmospheric pressure, 
contributed to a decreased need for red blood cells, and iron pools were consequently shifted 
fiom hemoglobin to a storage form. This process, termed neocytolysis, has been documented in 
spaceflight (20,21), as well as in subjects traveling from high to low altitude (22). 
While ferritin iron content did not increase along with the increased serum ferritin, ferritin 
iron and serum iron both tended to go up during the dive. One possibility for lack of significance 
is the small sample size (n = 6 for pre dive, MD 7, R + 0, and R + 7; n = 5 for MD 12). Another 
possibility is that the increase in total serum ferritin is indicative of recruitment of ferritin from 
preexisting stores, and that the time course is too short for enrichment of ferritin with excess iron 
to alter the reflection in the serum. There is also a possibility that the changes of serum ferritin 
during the dive were due to an acute inflammatory response since there were other indications 
that such a response might have occurred. Other acute phase proteins tended to go up during the 
dive. While not significant, serum C-reactive protein tended to be elevated during the dive 
compared to pre and post dive. The large variances prevented these findings from being 
significant. Again, we are limited with the very small sample size in this study. Furthermore, 
259 
260 
26 1 
262 
263 
264 
265 
266 
267 
268 
269 
270 
27 1 
272 
273 
274 
275 
276 
277 
278 
279 
280 
28 1 
other studies suggest that oxidative stress is increased during the acute inflammatory phase of 
many illnesses (24,25), which was also observed in one subject prior to the dive. 
Alterations in antioxidant markers were hypothesized due to the hyperbaric environment. 
Along with the increased 80HdG excretion observed during the dive, decreased activities of 
GPX and SOD post (GPX and SOD) and in-dive (SOD) imply increased oxidative stress. A 
number of other parameters (besides the environment) could have contributed to this, including 
changes in nutrient intake or changes in stress hormones. The significant decrease in MDA 
suggests that lipid peroxidation is decreased in and post dive compared to pre dive, which does 
not support the theory of increased oxidative damage. This decrease is not easily explained since 
we would have expected to see similar changes during the dive for 80HdG and MDA. Pre dive 
measurements for all parameters are averages of measurements recorded twice before the dive, 
and there appeared to be differences between the two collection points (pre dive day 12 for MDA 
was high compared to pre dive day 1; specifically 1.25 k 0.96 and 0.26 k 0.18 pmol/L for pre 
dive days 12 and 1, respectively). If only pre dive day 1 was used for comparison (instead of the 
average of the two), MDA then tended to increase during the dive compared to pre and post dive. 
Mean body weights were significantly lower than pre dive weights during the latter part of the 
dive (MD 7-14). During the dive, energy intakes were lower than World Health Organization 
recommendations (Table 1). This is a similar phenomenon that consistently occurs during 
spaceflight (6,26,27), and explains why body weights were concurrently decreased. Serum leptin 
was measured in these individuals and we found that these concentrations tended to go down 
during the dive and were significantly decreased by the last day (R + 0). Leptin is normally 
involved in the regulation of food intake and in the maintenance of energy balance, but its role in 
the decreased energy intake in this study is unknown and warrants further investigation. Other 
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studies have linked decreased leptin concentration with periods of intense exercise, possibly 
indicative of increased stress or inflammation (28,29). Again, consistent with other findings 
outlined above, the decreased leptin observed here may support the presence of an acute 
inflammatory response during the dive. 
Despite increased pressure in the habitat, there was no evidence for alterations in bone 
formationhesorption during the dive. While osteocalcin was significantly higher post dive (R + 
7) compared to in-dive (MD 7 and MD 12), other bone formation markers in the serum, 
including alkaline phosphatase and bone-specific alkaline phosphatase, were unchanged during 
the study. Bone resorption markers were unchanged during the dive. Parathyroid hormone and 
vitamin D concentrations tended to decrease, but not significantly. Both of these indices might 
have reached statistical significance with a longer mission (due to lack of ultraviolet light 
exposure) or with additional subjects. Furthermore, these findings enhance our recent 
observations that lower body negative pressure (LBNP) can mitigate disuse-induced bone 
resorption (30). The current study, one of whole body positive pressure, suggests that the 
findings with LBNP may be more related to circulatory changes than to pressure itself. Such 
suggestions that circulatory influences may impact weightlessness-induced bone loss are not new 
(31,32). 
It is evident that there are indeed many physiological and nutritional changes that occurred 
during NEEMO V that are also commonly observed during spaceflight. Changes in nutritional 
status during spaceflight are of critical concern for fbture long duration space travel, and 
spaceflight analogs such as NEEMO V may be increasingly important to further investigate 
potential countermeasures. 
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397 Table 1. Body weight and dietary intake data from NEEM0 V'. 
PRE MD2 MDJ I D 4  MD5 MDB MD7 MD8 MDS MDIO ID11 
Energy Intake, kcal ~ 2590 f 613 2660 f 925 2600 f 851 2010 f 886'' 1790 f 654" 2384 f 658 2380 t 510 2550 f 471 2400 f 688 21 10 f 362" 
Energy Intake (% WHO) ~ 9 0 0 t 7 2  922f211 896f16.2 714f279 60.96129 83.1f178 83.3f10.6 910f174  825fS5 751f124 
Water Intake. mL - 3000f999 3260f9i2 2510f751 iSBDfMl9 i9iOf1140 2410f877 2790f81D 3810f1960 2680t lZ IO 2200t634 
BW t w  7601161 752f166  754t159  751f162  750f18.0 750f15.5 74.6f157' 74.3f158' 745f159' 74.6t156' 742f158' 
Body Mass (OEM) (b) 68 9 f 17 3 - 
Body Fat (&I) 1 5 3 f 2 3  - 
BMC 2 d f 0 7  
LBM (ks) 5211145 ~ 
398 
399 'BW, body weight; BMC, bone mineral content; LBM, lean body mass. Values are means & SD, 
400 n = 6.  **Energy intake is significantly different from WHO recomendations (P < 0.05). 
401 "Significantly different from pre dive (P < 0.05). 
402 
403 
404 
405 
406 
407 
Table 2. Hernotologic, iron, and folate status indicators before, during, and after NEEM0 VI. 
Serum Hgb, g/L 
Serum HCT 0.41 f 0.04aC 0.41 f 0.03aC 0.40 f 0.04cd 0.38 k 0.04bd 0.40 f 0.04cd 
Serum MCV, fL 91 f3"b 92 f 3" 92 f 4" 92 f 3" 90 f 2bc 
Serum Iron, umol/L 19 f 7aC 26 f IOa 27 f IOa 22 k !jac 12 f qbc 
Ferritin Iron, umol/L 0.34f0.15 0.48f0.19 0.44f0.17 0.47f0.17 0.32f0.12 
Serum Ferritin, ug/L 102 f 63a 168 f 82b 219 f 98b 196 f 92b 117 f 70a 
Ferritin Saturation, % 22.8 f 9.2 18.2 f 8.7 12.0 f 3.2 14.6 f 3.8 18.6 f 8.5 
Transferrin Receptors, ug/mL 4.8 f 1 .3aC 4.6 k 1 .Icd 4.3 f 0.8cd 3.9 f O.gbd 4.1 f l.Ocd 
Transferrin, g/L 2.63 f 0.18 2.66 f 0.29 2.65 f 0.14 2.53 f 0.24 2.62 f 0.18 
RBC Folate, nmol/L 1705f486 1598f575 1683f365 1445f486 1554f429 
Hgb, hemoglobin; HCT, hematocrit; MCV, mean corpuscular volume; RBC, red blood cell. 
Values are means -I SD, n = 6 (n = 5 on MD 12 for all parameters, except transferrin receptors 
where n = 6 for all days). Significant differences in rows are represented by different letters (P < 
0.05). 
1 
408 Table 3. General blood chemistry before, during, and after NEEM0 V'. 
Serum Sodium, mmollL 
Serum Potassium, mmol/L 4.2 f 0.3 4.1 f 0.2 4.2 f 0.7 3.9 f 0.3 4.3 f 0.2 
Serum Chloride, mmol/L 106 f 2 106 f 3 105 f 3 105 f 2 107 f 3 
Serum Creatinine, umol/L 94 k 13 94f 13 77 f 40 93f  17 94 f 16 
Serum Triglyceride, mmollL 1.03 f 0.34 1.07 f 0.38 1 .I3 f 0.62 1.54 f 0.55 1.72 f 1 .OO 
Serum RBP, mg/L 67.4 f 7.21 58.8 f 17.9 59.3 f 11.4 55.0 f 11.2 65.3 f 13.4 
RBC GSH Activity, % act 13.9 f 9.95 7.2 f 10.5 5.7 f 5.0 6.0 f 7.6 10.4 f 4.9 
RBC Transaminase act, % aci 81.6 f 13.4 86.0 f 15.4 79.5 f 16.6 86.7 f 15.4 82.1 f 13.8 
Serum ATL, UIL 18.4 f 7.0 13.8 f 6.2 16.2 f 4.8 14.2 k 3.5 18.8 f 6.9 
Serum AST, UIL 25.9 f 2.6 29.7 f 4.6 29.6 f 10.6 26.2 f 3.9 25.3 f 5.8 
Serum Ceruloplasmin, mg/L 430 f 130a 470 f 150ab 480 f 120ab 520 f 120b 500 f 140ab 
Serum Transthyretin, mg/L 305 f 58 285 f 24 312 f 22 305 f 38 327 f 59 
Serum Cholesterol, mmol/L 5.15 f 0.67 5.14 f 1.10 4.26 f 2.26 4.78 f 0.86 5.31 f 0.91 
Serum pH 7.4 f 0.02 7.4 f 0.02 7.4 f 0.05 7.4 f 0.02 7.4 f 0.04 
Total protein, g/L 68 f 4  70 f 3 70 f 7 70 f 3 6 9 f 4  
Leptin, nglmL 5.8 f 3.5ab 4.2 f 2.6b 2.7 f 1 .2b 2.3 f 1.1' 5.6 f 2.4bd 
CRP, mg/L 1.8f1.9 11.9f18.1 12.4f23.3 4.7f7.4 2.1 f 2.4 
Albumin, g/L 4 3 f 3  4 6 f 2  4 5 f 3  4 5 f 3  4 5 f 3  
409 
410 'RBP, retinol binding protein; RBC, red blood cell; GSH, glutathione reductase; ALT, alanine 
41 1 aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein. Values are means 
412 k SD, n = 6 (n = 5 on MD 12 for all parameters except for serum RBP, where n = 6 for all days). 
41 3 Significant differences in rows are represented by different letters (P < 0.05). 
414 Table 4. General urine chemistry before, during, and after NEEM0 V’. 
Urine pH 
Urine excretion volume, mL 
Urine Sodium, mmol/d 
Urine Potassium, mmol/d 
Urine Chloride, mmol/d 
Urine 3MH, umoWd 
Urine Iodine, mmolld 
Urine Mg, mmol/d 
Urine Phos, mmol/d 
Urine Creatinine. mmol/d 
415 
Pre 
6.0 f 0.16 
2160 f 676 
182 f 2Ia 
62.2 f 15.7” 
176 f lBa  
245 f 122 
2.46 f 0.91 
3.89 f 1.05 
30 i 7 
16.3 f 3.7 
MD 7 
6.22 f 0.41 
1970 f 1260 
120 f 71” 
47.3 f 15.0a 
98.5 f 60.4” 
242 f 138 
2.12 f 0.84 
4.34 f 1.39 
3 4 f  11 
15.2 f 5.2 
MD 12 R+O R + 1  
6.25 f 0.33 6.07 f 0.47 6.46 f 0.45 
2410f944 2670f1390 1670f647 
106 f 44b 98.7 f 32.1 124 f 42 
90.2 f 31.9” 87.7 f 30.6 107 f 24 
222f116 230f93 2702104 
1.77f0.71 2.68f1.13 1.80f0.29 
3.78 f 1.44 4.67 f 1.67 3.41 f 1.96 
3 3 f 1 2  2 7 f 1 0  2 3 f 8  
17.5 f 5.2 16.2 f 4.0 13.5 f 7.4 
53.0 f 1 8 . 5 ~  46.8 f 18.2 53.8 f 24.1 
R + 7  
6.21 f 0.55 
2110 f 1040 
163 f 31 
72.5 f 25.2 
159 f 25 
271 f 112 
2.18 A 0.96 
4.43 f 0.94 
29f11 
16.3 f 4.0 
R + 0  
6.04 f 0.31 
2620 f 1940 
191 f 58 
64.8 f 20.7 
193 f 69 
269f114 
2.60 f 1.39 
5.06 f 1.60 
29 f 6 
16.1 f 3.5 
416 ‘3MH, 3-methylhistidine. Values are means k SD, n = 6 (n = 5 on R + 1). Significant 
417 differences in rows are represented by different letters 0) < 0.05). 
418 
419 
420 
42 1 
422 
423 
424 
425 
Table 5. Calcium and bone markers before, during, and after NEEM0 V' . 
7.43 f 1 .0za 
61.0 f 17.7 
20.7 f 7.20 
86 f 30 
212f  105 
2.70 f 0.18 
1.23 f 0.05 
73.7 f 24.9 
690 f 384 
307 f 85 
4.83 f 1.85" 
7.75 f 1 .46a 
66.6 f 20.0 
21.4 f 8.60 
81 f 18 
221 f 80.6 
2.57 f 0.15 
1.26 f 0.02. 
3.98 f 0.9Ia 
70.2 f 20.2 
480 f 287 
292 f 78 
6.35 f 1.73= 
61.7 f 22.3 
21.7 f 8.06 
86 f 18 
198 f 108 
2.57 f 0.10 
1.21 f 0.03 
5.13 f 1.51" 
61.6 f 15.5 
430 f 208 
297 f 98 
4.92 f 1.21" 
60.3 f 8.6 
499 f 271 
224 f 68 
10.7 f 2.9Ok 
61.3 f 21.5 
19.7 f 7.45 
81 f 2 4  
201 f 64.1 
2.67 f 0.22 
1.21 f 0.03' 
6.12 f 2.33" 
66.8 f 17.3 
539 f 363 
285 f 87 
Pie MD 7 MD 12 R + O  R + 1  R + 7  R + 8  
Serum PTH, pg/mL 31.1f7.82 25.8f9.72 24.3f6.87 28.0f10.2 29.6 f 9.81 
Serum Osteocalcin, ng/mL 
Alk P'ase 
9.30 f 2.10" 
Serum total Alk Phosphata 57.7 f 22.0 
Serum BSAP, UIL 21.7 f 7.00 
92 f 23 
21 1 f 52.4 
Serum TCa, mmol/L 2.56 f 0.1 1 
Serum ICa, mmoWL 1.18 f0.03 
Urine Ca, mmol/L 5.49 f 0.73= 
DPD, nmol/d 63.9 f 7.4 
NTX, nmol/d 464 f 235 
PYD, nmol/d 256 f 51 
Serum 25 OH Vit D, nmol/L 
Serum 125 OH Vit D, pmol/L 
Calcium 
6.82 f 2.1 ah" 
57.0 f 19.8 
556 f 240 
260 f 89 
'iPTH, intact parathyroid hormone; Alk Phosphatase, alkaline phosphatase; BSAP, bone-specific 
alkaline phosphatase; DPD, deoxypyridinoline; NTX, n-telopeptide; PYD, pyridinium crosslinks. 
Values are means rt SD, n = 6 (n = 5 on MD 12 fortotal alkaline phosphatase and n = 5 on R + 1 
for DPD, NTX, and PYD). Significant differences in rows are represented by different letters (P 
< 0.05). *Significantly different from pre dive (P < 0.05). 
426 Table 6. Antioxidant/oxidative damage indices fiom NEEM0 V crew members'. 
Pre MD 7 MD 12 R + O  R + 7  
8(0H)dG, ug/d 
GPX, U/g Hgb 63.8f6.4a 54.1 f9.1ab 58.6f9.Tb 53.1 k9.2ab 48.1 f7.2b 
MDA, umol/L 0.75 f 0.46a 0.61 f 0.22ab 0.60 f 0.2!iab 0.26 f 0.13b 0.20 f O.O!jb 
SOD, U/g Hgb 1240 f 185a 877 f 173b 912 f 18!jb 1030 f 170b 997 rt 10lb 
TAC, mmol/L 1.12f0.03 1.15f0.15 1.39k0.47 1.06f0.09 1.12f0.06 
427 
428 '8(0H)dG, 8-hydroxy-2'deoxyguanosine; GPX, glutathione peroxidase; MDA, 
429 malondialdehyde; SOD, superoxide dismutase; TAC, total antioxidant capacity. Values are 
430 
43 1 
432 
means I- SD, n = 6 (n = 5 for GPX, MDA, and SOD for MD 12 and n = 5 for 8(OH)dG on R + 
1). Significant differences in rows are represented by different letters (P < 0.05). 
